Skip to content
2000
Volume 7, Issue 11
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

CXCR3 and CCR5 are chemokine receptor that are predominantly expressed on the surface of Th1 polarized T cells. In a variety of human and experimental autoimmune diseases the enhanced expression of CXCR3 and CCR5 binding chemokine ligands is followed by the recruitment of CXCR3- and CCR5-positive T cells, indicating an important role for these chemokine receptors in T cell-mediated tissue damage. In this review, we summarize a number of in vivo studies available on the neutralization of CXCR3 and CCR5 in inflammatory disease, and specifically focus on the potential therapeutic effects of CXCR3 and CCR5 blockade in human autoimmune disease and organ transplantation.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/138955707782331768
2007-11-01
2025-06-20
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/138955707782331768
Loading

  • Article Type:
    Research Article
Keyword(s): autoimmune disease; Chemokine receptor; inflammation; T cell; transplantation
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test